protease deficiency plasma patient cystic fibrosis reduced reaction 4methylumbelliferylguanidinobenzoate plasma patient cystic fibrosis protease activity plasma assayed using 4 methylumbelliferylguanidinobenzoate assay modified carrying reaction presence absence benzamidine competitive inhibitor trypsinlike protease parameter assay described detail using assay earlier demonstration deficiency protease activity plasma patient cystic fibrosis confirmed activity corrected nonspecific hydrolysis 4 methylumbelliferylguanidinobenzoate benzamidine expressed nanomoles 4methylumbelliferone released per milliliter plasma standard condition activity plasma activated chloroformellagic acid 1272 231 7 control 704 117 11 obligate heterozygote 487 166 12 patient cystic fibrosis identical result obtained unactivated plasma used data demonstrate judicious use specific inhibitor benzamidine might useful assaying low level protease activity crude system